SCHEMBL19124503

SCHEMBL19124503

CN(C)[C@@H]1CCCC[C@H]1N(C)Cc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.40
NTRK1 P04629 1/20 0.40
FYN P06241 1/20 0.40
RET P07949 1/20 0.40
MET P08581 1/20 0.40
PDGFRB P09619 1/20 0.40
PIM1 P11309 1/20 0.40
FGFR1 P11362 1/20 0.40
PDGFRA P16234 1/20 0.40
LTK P29376 1/20 0.40
MAP2K2 P36507 1/20 0.40
FLT3 P36888 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
CDK8 P49336 1/20 0.40
GSK3B P49841 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
NEK2 P51955 1/20 0.40
JAK3 P52333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11591649 0.83 CHEK1 (0.56) CHEK1NTRK1FYNRETMET
SCHEMBL3214124 0.73 HSD17B10 (0.50) CYP1A2CYP2C9CYP2D6HSD17B10CYP2C19
SCHEMBL11589745 0.73 CYP2D6 (0.49) CHEK1NTRK1FYNRETMET
SCHEMBL11592409 0.72 CYP2D6 (0.55) CHEK1NTRK1FYNRETMET
SCHEMBL16440896 0.72 CYP2D6 (0.47) CYP1A2CYP2C9CYP2D6HSD17B10CYP2C19
SCHEMBL19130458 0.72 CYP2D6 (0.47) CYP1A2CYP2C9CYP2D6HSD17B10CYP2C19
SCHEMBL19124504 0.72 CYP2D6 (0.47) CYP1A2CYP2C9CYP2D6HSD17B10CYP2C19
SCHEMBL19149261 0.71 SLC18A3 (0.35) CYP2D6TSHREGFRCYP3A4HTT
SCHEMBL19124267 0.71 CYP2D6 (0.39) CHEK1NTRK1FYNRETMET
SCHEMBL19124754 0.71 CYP2D6 (0.41) CYP1A2CYP2C9CYP2D6HSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines UNIVERSITY COLLEGE DUBLIN (IE) 2019-02-05 US disclosed
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines UNIVERSITY COLLEGE DUBLIN (IE) 2019-02-05 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES UNIVERSITY COLLEGE DUBLIN (IE) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196338-B2 Chiral diamine compounds for the preparation of chiral alcohols and chiral amines ADH1C, ADH1A, ADH5 CHEK1 2581/4885NTRK1 2083/4885FYN 4619/4885
US-20170204036-A1 CHIRAL DIAMINE COMPOUNDS FOR THE PREPARATION OF CHIRAL ALCOHOLS AND CHIRAL AMINES ADH1C, ADH1A, ADH5 CHEK1 2501/4885NTRK1 2154/4885FYN 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.